{"prompt": "['2016N293064_03', 'CONFIDENTIAL', '2018N394263_00', '205864', '12.8.', 'Appendix 8: Medical Device Incidents: Definition and', 'Procedures for Recording, Evaluating, Follow-up, and', 'Reporting', 'Definition and Documentation of Medical Device Incidents', 'Definitions of a Medical Device Incident', 'The detection and documentation procedures described in this protocol apply to all GSK', 'medical devices provided for use in the study (see Section 7.1.1) for the list of GSK', 'medical devices).', 'Medical Device Incident Definition', 'A medical device incident is any malfunction or deterioration in the characteristics', 'and/or performance of a device as well as any inadequacy in the labeling or the', 'instructions for use which, directly or indirectly, might lead to or might have led to', 'the death of a participant/user/other person or to a serious deterioration in his/her', 'state of health.', 'Not all incidents lead to death or serious deterioration in health. The nonoccurrence', 'of such a result might have been due to other fortunate circumstances or to the', 'intervention of health care personnel.', 'It is sufficient that:', 'An incident associated with a device happened and', 'The incident was such that, if it occurred again, might lead to death or a serious', 'deterioration in health.', 'A serious deterioration in state of health can include any of the following:', 'Life-threatening illness', 'Permanent impairment of body function or permanent damage to body structure', 'Condition necessitating medical or surgical intervention to prevent one of the', 'above', 'Fetal distress, fetal death, or any congenital abnormality or birth defects', '78']['2016N293064_03', 'CONFIDENTIAL', '2018N394263_00', '205864', 'Examples of incidents', 'A participant, user, caregiver, or healthcare professional is injured as a result of a', 'medical device failure or its misuse.', \"A participant's study treatment is interrupted or compromised by a medical device\", 'failure.', 'A misdiagnosis due to medical device failure leads to inappropriate treatment.', \"A participant's health deteriorates due to medical device failure.\", 'Documenting Medical Device Incidents', 'Medical Device Incident Documenting', 'Any medical device incident occurring during the study will be documented in the', \"participant's medical records, in accordance with the investigator's normal clinical\", 'practice, and on the appropriate form.', 'For incidents fulfilling the definition of an AE or an SAE, the appropriate AE/SAE', 'CRF page will be completed as described in Appendix 4.', 'The form will be completed as thoroughly as possible and signed by the investigator', 'before transmittal to the GSK.', 'It is very important that the investigator provides his/her assessment of causality', '(relationship to the medical device provided by GSK) at the time of the initial report', 'and describes any corrective or remedial actions taken to prevent recurrence of the', 'incident.', 'A remedial action is any action other than routine maintenance or servicing of a', 'medical device where such action is necessary to prevent recurrence of an incident.', 'This includes any amendment to the device design to prevent recurrence.', '79']['2016N293064_03', 'CONFIDENTIAL', '2018N394263_00', '205864', '12.9.', 'Appendix 9: Neutrophil Safety and Study Treatment Restart', 'Neutrophil Stopping Criteria: Absolute neutrophil count (ANC) 0.5 X 109 /L', 'Required Actions and Follow up Assessments', 'Actions', 'Follow Up Assessments', 'Immediately discontinue study treatment', 'Record the appearance or', 'worsening of any clinical', 'Report the event to GSK within 24 hours', 'symptoms on the AE report form\u00b9', 'Complete an SAE data collection tool if the', 'event also meets the criteria for an SAE', 'Obtain blood sample for', 'pharmacokinetic (PK) analysis', 'Monitor the participant until neutrophil', 'within 12 hours after last dose\u00b2', 'count stabilizes or returns to within', 'Record use of concomitant', 'baseline (see MONITORING below)', 'medications on the concomitant', 'Do not restart participant with study', 'medications report form', 'treatment unless allowed per protocol and', 'GSK Medical Governance approval is', 'granted (see RESTART below)', 'MONITORING:', 'Treatment of any suspected infections\u00b9', 'Repeat CBC within 24 hrs', 'Monitor CBC daily until neutrophil count', 'resolves, stabilizes or returns to within', 'baseline', 'RESTART', 'Restart of study medication must be', 'Check the CBC within 24-48 hours', 'approved by the GSK Medical Monitor', 'after re-starting study medication,', 'Restart may be attempted ONLY if all', 'monitor twice weekly for two', 'three criteria are met:', 'weeks, and monthly thereafter.', 'The neutrophil count is 1.5 X 109/L', 'If the ANC drops below 1.0 X', 'for at least 48 hours', '109/L on restart, the participant', 'At least 7 days have elapsed since the', 'should be permanently', 'suspension of study treatment', 'discontinued from study treatment', 'No sign or symptom of associated', 'and withdrawn from the study.', 'infection has been identified', '80']\n\n###\n\n", "completion": "END"}